Table 1. Basal characteristics of 133 patients with prostate carcinoma.
| Without biochemical recurrence (n=86) | With biochemical recurrence (n=47) | ||
|---|---|---|---|
| Characteristics | No. (%) | No. (%) | P-value |
| Age (year) | NS | ||
| <65 | 52 (39.5) | 28 (40.4) | |
| >65 | 34 (60.5) | 19 (59.6) | |
| Tumoural stage | <0.0001 | ||
| T2 | 79 (91.9) | 27 (57.4) | |
| T3–4 | 7 (8.1) | 20 (42.6) | |
| Gleason grading | <0.003 | ||
| 2–4 | 14 (16.3) | 4 (8.5) | |
| 5–6 | 50 (58.1) | 17 (36.2) | |
| 7–10 | 22 (25.6) | 26 (55.3) | |
| PSA (ng ml–1) | NS | ||
| <10 | 65 (75.6) | 28 (59.6) | |
| >10 | 21 (24.4) | 19 (40.4) | |
Abbreviations: NS=not significant; PSA=prostate-specific antigen.